Evidence map›Paper›PMID 29242055›Full record

ArticleThe American journal of pathology2018

Late Disseminated Lyme Disease: Associated Pathology and Spirochete Persistence Posttreatment in Rhesus Macaques.

Nicholas A Crossland, Xavier Alvarez, Monica E Embers

Open access · hybridAbstract read
In one paragraph

Article in The American journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Characterization ofMicroorganisms · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Hitchhiker's Guide toJournal of bacteriology · 2024
    Review
  7. Suppression of host humoral immunity byInfection and immunity · 2024
    Article
  8. Direct Detection of Borrelia Species in Tissues.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  9. Development of Organoids to Study Infectious Host Interactions.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  10. Unguarded liabilities:Frontiers in antibiotics · 2024
    Article
  11. Review
  12. The In Vitro Antimicrobial Susceptibility ofPathogens (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Persistent Borrelia burgdorferiClinical microbiology reviews · 2022
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nicholas A CrosslandDivision of Bacteriology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, Louisiana; Division of Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, Louisiana.
Xavier AlvarezDivision of Comparative Pathology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, Louisiana.
Monica E EmbersDivision of Bacteriology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, Louisiana; Division of Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, Louisiana. Electronic address: members@tulane.edu.
Tulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
TNF AND MCP-1 IN RETROVIRUS-INDUCED BRAIN DISEASEP20RR020159 · NCRR · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KOUSOULAS, KONSTANTIN G · 2004 to 2011
$16.1M
Research Training in Experimental Medicine and PathologyT32OD011124 · OD · TULANE UNIVERSITY OF LOUISIANA · PI BLAIR, ROBERT, RAPPAPORT, JAY · 2012 to 2019
$2.7M
Leica TCS SP8 Confocal Microscope SystemS10OD019964 · OD · TULANE UNIVERSITY OF LOUISIANA · PI LACKNER, ANDREW A · 2015 to 2015
$478k
NCRR NIH HHS P20 RR020159NIH HHS P51 OD011104NIH HHS S10 OD019964NIH HHS T32 OD011124
6 · The paper itself

Abstract

Nonhuman primates currently serve as the best experimental model for Lyme disease because of their close genetic homology with humans and demonstration of all three phases of disease after infection with Borrelia burgdorferi. We investigated the pathology associated with late disseminated Lyme disease (12 to 13 months after tick inoculation) in doxycycline-treated (28 days; 5 mg/kg, oral, twice daily) and untreated rhesus macaques. Minimal to moderate lymphoplasmacytic inflammation, with a predilection for perivascular spaces and collagenous tissues, was observed in multiple tissues, including the cerebral leptomeninges, brainstem, peripheral nerves from both fore and hind limbs, stifle synovium and perisynovial adipose tissue, urinary bladder, skeletal muscle, myocardium, and visceral pericardium. Indirect immunofluorescence assays that combined monoclonal (outer surface protein A) and polyclonal antibodies were performed on all tissue sections that contained inflammation. Rare morphologically intact spirochetes were observed in the brains of two treated rhesus macaques, the heart of one treated rhesus macaque, and adjacent to a peripheral nerve of an untreated animal. Borrelia antigen staining of probable spirochete cross sections was also observed in heart, skeletal muscle, and near peripheral nerves of treated and untreated animals. These findings support the notion that chronic Lyme disease symptoms can be attributable to residual inflammation in and around tissues that harbor a low burden of persistent host-adapted spirochetes and/or residual antigen.

Indexed as

AnimalsAnti-Bacterial AgentsBrainDoxycyclineInflammationLyme DiseaseMacaca mulattaMaleMuscle, SkeletalMyocardiumPericardiumAnti-Bacterial AgentsDoxycycline

Identifiers

PMID29242055
PMCPMC5840488
OpenAlexW2773880284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.